Publication | Open Access

MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II–III HER2-positive breast cancer (TRAIN-3): a multicentre, single-arm, phase 2 study

Neoadjuvant Chemotherapy DurationBreast OncologyMedical ImagingMedicineMri-guided OptimisationBreast ImagingBreast CancerCancer TreatmentMri-guided Radiation TherapyOncologyRadiation OncologyRadiologyHealth Sciences